Predicting response to immunotherapy in gastric cancer via multi-dimensional analyses of the tumour immune microenvironment

A single biomarker is not adequate to identify patients with gastric cancer (GC) who have the potential to benefit from anti-PD-1/PD-L1 therapy, presumably owing to the complexity of the tumour microenvironment. The predictive value of tumour-infiltrating immune cells (TIICs) has not been definitive...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yang, Jia, Keren, Sun, Yu, Zhang, Cheng, Li, Yilin, Zhang, Li, Chen, Zifan, Zhang, Jiangdong, Hu, Yajie, Yuan, Jiajia, Zhao, Xingwang, Li, Yanyan, Gong, Jifang, Dong, Bin, Zhang, Xiaotian, Li, Jian, Shen, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388563/
https://www.ncbi.nlm.nih.gov/pubmed/35982052
http://dx.doi.org/10.1038/s41467-022-32570-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388563/
https://www.ncbi.nlm.nih.gov/pubmed/35982052
http://dx.doi.org/10.1038/s41467-022-32570-z

Ejemplares similares